Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Lasilactone capsules (Mawdsley-Brooks & Company Ltd) 30 capsule |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 25 transdermal patches (Mawdsley-Brooks & Company Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 50 transdermal patches (Mawdsley-Brooks & Company Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 75 transdermal patches (Mawdsley-Brooks & Company Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 100 transdermal patches (Mawdsley-Brooks & Company Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 25 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 50 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 75 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Durogesic DTrans 100 transdermal patches (Mawdsley-Brooks & Company Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Chlorhexidine gluconate 0.02% solution |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Stannous fluoride 0.4% dental gel sugar free |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely fluphenazine hydrochloride 1 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Perindopril erbumine 4mg / Indapamide 1.25mg tablets (Alliance Healthcare (Distribution) Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Perindopril erbumine 4mg / Indapamide 1.25mg tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet 3 x 10 tablets |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Compound Syrup of Glycerin, Lemon & Honey (Bell,Sons & Co (Druggists) Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Amiloride 5mg / Bumetanide 1mg tablets (Chemidex Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Compound Syrup of Glycerin, Lemon & Honey (Bell,Sons & Co (Druggists) Ltd) 200 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Amiloride 5mg / Bumetanide 1mg tablets (Chemidex Pharma Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Pericyazine 10mg/5mL syrup |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Bell's Glycerin and Blackcurrant Cough syrup (Bell,Sons & Co (Druggists) Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Zentiva Pharma UK Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Actavis UK Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Paracetamol 1g oral powder sachets 8 sachet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Bell's Glycerin and Blackcurrant Cough syrup (Bell,Sons & Co (Druggists) Ltd) 200 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) 5 sachet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) 8 sachet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Flu Strength Hot Lemon Powders 1g oral powder sachets (Bell,Sons & Co (Druggists) Ltd) 10 sachet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Zentiva Pharma UK Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Triamcinolone acetonide 40mg/mL injection suspension 1mL prefilled syringe |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Macrogol 4000 10g oral powder sachets sugar free |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sodium chloride 2.7% solution for injection 500ml polyethylene bottles |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Viatris UK Healthcare Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Dexcel-Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Viatris UK Healthcare Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Dexcel-Pharma Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (A A H Pharmaceuticals Ltd) 28 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Teva UK Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Alliance Healthcare (Distribution) Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet 2 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely efavirenz 100 milligram/1 each conventional release oral capsule |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Generic Eno effervescent powder sugar free |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely lornoxicam 8 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Phytomenadione 1mg capsules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Pericyazine 10mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Pericyazine 10mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) 100 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
GlucoRx lancets 0.31mm/30gauge (Disposable Medical Equipment Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
GlucoRx lancets 0.31mm/30gauge (Disposable Medical Equipment Ltd) 200 lancet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely ifosfamide 1 gram/1 vial powder for conventional release solution for injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely ifosfamide 2 gram/1 vial powder for conventional release solution for injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Naloxone hydrochloride 20mcg/mL injection solution 2mL ampule |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Squill liquid extract |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Pericyazine 10mg/5ml oral solution (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Pericyazine 10mg/5ml oral solution (A A H Pharmaceuticals Ltd) 100 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Somatropin (rbe) 4.95mg/1.5ml solution for injection cartridges |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Gentamicin 10mg/mL injection solution 2mL vial |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Tilade 2mg/dose inhaler CFC free (Mawdsley-Brooks & Company Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Tilade 2mg/dose inhaler CFC free (Mawdsley-Brooks & Company Ltd) 112 dose |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Generic Burns cream |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dermablend cover creme cafe (Vichy) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dermablend cover creme chocolate (Vichy) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dermablend cover creme olive (Vichy) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dermablend cover creme cafe (Vichy) 6 gram |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dermablend cover creme chocolate (Vichy) 6 gram |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dermablend cover creme olive (Vichy) 6 gram |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cephradine 250mg/5mL syrup |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely phenylbutazone 200 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Generic Dermablend setting powder |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Circadin 2mg modified-release tablets (Sigma Pharmaceuticals Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Feminax Express 342mg tablets (Bayer Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Neokay 1mg capsules (Neoceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Phytomenadione 1mg capsules 12 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ibuprofen lysine 200mg tablets 8 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Circadin 2mg modified-release tablets (Sigma Pharmaceuticals Plc) 21 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Feminax Express 342mg tablets (Bayer Plc) 8 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Feminax Express 342mg tablets (Bayer Plc) 16 tablet 2 x 8 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Neokay 1mg capsules (Neoceuticals Ltd) 12 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Neokay 1mg capsules (Neoceuticals Ltd) 100 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Chlorhexidine gluconate 5% concentrated solution |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Chamomile extracts 10.5% ointment |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sunsense lip balm SPF 50 (Ego Pharmaceuticals) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sunscreen lip balm 15 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sunsense lip balm SPF 50 (Ego Pharmaceuticals) 15 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Arrow Generics Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Arrow Generics Ltd) 28 tablet 4 x 7 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (clinical drug) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Vapor-permeable adhesive film dressing with absorbent pad 6cm x 7cm |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Nabilone 1mg capsules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 25micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 50micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 75micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 100micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Nabilone 1mg capsules (A A H Pharmaceuticals Ltd) 20 capsule |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 25micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Fentanyl 50micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) 5 patch |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|